Haemophilia Treatment Market, Global Outlook and Forecast 2022-2028
Haemophilia is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding.
This report contains market size and forecasts of Haemophilia Treatment in global, including the following market information:
Global Haemophilia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Haemophilia Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Haemophilia Treatment companies in 2021 (%)
The global Haemophilia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Haemophilia A Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Haemophilia Treatment include Bayer, Novo Nordisk, Pfizer, Roche, Aptevo Therapeutics, Catalyst BioSciences, Dimension Therapeutics, Takeda and CSL Behring and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Haemophilia Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Haemophilia Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Haemophilia Treatment Market Segment Percentages, by Type, 2021 (%)
Global Haemophilia Treatment Market Segment Percentages, by Application, 2021 (%)
Global Haemophilia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Haemophilia Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Haemophilia Treatment revenues share in global market, 2021 (%)
Key companies Haemophilia Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Haemophilia Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Haemophilia Treatment in global, including the following market information:
Global Haemophilia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Haemophilia Treatment Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Haemophilia Treatment companies in 2021 (%)
The global Haemophilia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Haemophilia A Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Haemophilia Treatment include Bayer, Novo Nordisk, Pfizer, Roche, Aptevo Therapeutics, Catalyst BioSciences, Dimension Therapeutics, Takeda and CSL Behring and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Haemophilia Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Haemophilia Treatment Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Haemophilia Treatment Market Segment Percentages, by Type, 2021 (%)
- Haemophilia A
- Haemophilia B
Global Haemophilia Treatment Market Segment Percentages, by Application, 2021 (%)
- Hospital
- Pharmaceutical Companies
- Other
Global Haemophilia Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Haemophilia Treatment revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Haemophilia Treatment revenues share in global market, 2021 (%)
Key companies Haemophilia Treatment sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Haemophilia Treatment sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bayer
- Novo Nordisk
- Pfizer
- Roche
- Aptevo Therapeutics
- Catalyst BioSciences
- Dimension Therapeutics
- Takeda
- CSL Behring
- Alnylam Pharmaceuticals
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Haemophilia Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Haemophilia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HAEMOPHILIA TREATMENT OVERALL MARKET SIZE
2.1 Global Haemophilia Treatment Market Size: 2021 VS 2028
2.2 Global Haemophilia Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Haemophilia Treatment Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Haemophilia Treatment Players in Global Market
3.2 Top Global Haemophilia Treatment Companies Ranked by Revenue
3.3 Global Haemophilia Treatment Revenue by Companies
3.4 Global Haemophilia Treatment Sales by Companies
3.5 Global Haemophilia Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Haemophilia Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Haemophilia Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Haemophilia Treatment Players in Global Market
3.8.1 List of Global Tier 1 Haemophilia Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Haemophilia Treatment Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Haemophilia Treatment Market Size Markets, 2021 & 2028
4.1.2 Haemophilia A
4.1.3 Haemophilia B
4.2 By Type - Global Haemophilia Treatment Revenue & Forecasts
4.2.1 By Type - Global Haemophilia Treatment Revenue, 2017-2022
4.2.2 By Type - Global Haemophilia Treatment Revenue, 2023-2028
4.2.3 By Type - Global Haemophilia Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Haemophilia Treatment Sales & Forecasts
4.3.1 By Type - Global Haemophilia Treatment Sales, 2017-2022
4.3.2 By Type - Global Haemophilia Treatment Sales, 2023-2028
4.3.3 By Type - Global Haemophilia Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Haemophilia Treatment Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Haemophilia Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Pharmaceutical Companies
5.1.4 Other
5.2 By Application - Global Haemophilia Treatment Revenue & Forecasts
5.2.1 By Application - Global Haemophilia Treatment Revenue, 2017-2022
5.2.2 By Application - Global Haemophilia Treatment Revenue, 2023-2028
5.2.3 By Application - Global Haemophilia Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Haemophilia Treatment Sales & Forecasts
5.3.1 By Application - Global Haemophilia Treatment Sales, 2017-2022
5.3.2 By Application - Global Haemophilia Treatment Sales, 2023-2028
5.3.3 By Application - Global Haemophilia Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Haemophilia Treatment Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Haemophilia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Haemophilia Treatment Revenue & Forecasts
6.2.1 By Region - Global Haemophilia Treatment Revenue, 2017-2022
6.2.2 By Region - Global Haemophilia Treatment Revenue, 2023-2028
6.2.3 By Region - Global Haemophilia Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Haemophilia Treatment Sales & Forecasts
6.3.1 By Region - Global Haemophilia Treatment Sales, 2017-2022
6.3.2 By Region - Global Haemophilia Treatment Sales, 2023-2028
6.3.3 By Region - Global Haemophilia Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Haemophilia Treatment Revenue, 2017-2028
6.4.2 By Country - North America Haemophilia Treatment Sales, 2017-2028
6.4.3 US Haemophilia Treatment Market Size, 2017-2028
6.4.4 Canada Haemophilia Treatment Market Size, 2017-2028
6.4.5 Mexico Haemophilia Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Haemophilia Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Haemophilia Treatment Sales, 2017-2028
6.5.3 Germany Haemophilia Treatment Market Size, 2017-2028
6.5.4 France Haemophilia Treatment Market Size, 2017-2028
6.5.5 U.K. Haemophilia Treatment Market Size, 2017-2028
6.5.6 Italy Haemophilia Treatment Market Size, 2017-2028
6.5.7 Russia Haemophilia Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Haemophilia Treatment Market Size, 2017-2028
6.5.9 Benelux Haemophilia Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Haemophilia Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Haemophilia Treatment Sales, 2017-2028
6.6.3 China Haemophilia Treatment Market Size, 2017-2028
6.6.4 Japan Haemophilia Treatment Market Size, 2017-2028
6.6.5 South Korea Haemophilia Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Haemophilia Treatment Market Size, 2017-2028
6.6.7 India Haemophilia Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Haemophilia Treatment Revenue, 2017-2028
6.7.2 By Country - South America Haemophilia Treatment Sales, 2017-2028
6.7.3 Brazil Haemophilia Treatment Market Size, 2017-2028
6.7.4 Argentina Haemophilia Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Haemophilia Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Haemophilia Treatment Sales, 2017-2028
6.8.3 Turkey Haemophilia Treatment Market Size, 2017-2028
6.8.4 Israel Haemophilia Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Haemophilia Treatment Market Size, 2017-2028
6.8.6 UAE Haemophilia Treatment Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Haemophilia Treatment Major Product Offerings
7.1.4 Bayer Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.1.5 Bayer Key News
7.2 Novo Nordisk
7.2.1 Novo Nordisk Corporate Summary
7.2.2 Novo Nordisk Business Overview
7.2.3 Novo Nordisk Haemophilia Treatment Major Product Offerings
7.2.4 Novo Nordisk Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.2.5 Novo Nordisk Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Haemophilia Treatment Major Product Offerings
7.3.4 Pfizer Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Haemophilia Treatment Major Product Offerings
7.4.4 Roche Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Roche Key News
7.5 Aptevo Therapeutics
7.5.1 Aptevo Therapeutics Corporate Summary
7.5.2 Aptevo Therapeutics Business Overview
7.5.3 Aptevo Therapeutics Haemophilia Treatment Major Product Offerings
7.5.4 Aptevo Therapeutics Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.5.5 Aptevo Therapeutics Key News
7.6 Catalyst BioSciences
7.6.1 Catalyst BioSciences Corporate Summary
7.6.2 Catalyst BioSciences Business Overview
7.6.3 Catalyst BioSciences Haemophilia Treatment Major Product Offerings
7.6.4 Catalyst BioSciences Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.6.5 Catalyst BioSciences Key News
7.7 Dimension Therapeutics
7.7.1 Dimension Therapeutics Corporate Summary
7.7.2 Dimension Therapeutics Business Overview
7.7.3 Dimension Therapeutics Haemophilia Treatment Major Product Offerings
7.7.4 Dimension Therapeutics Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.7.5 Dimension Therapeutics Key News
7.8 Takeda
7.8.1 Takeda Corporate Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Haemophilia Treatment Major Product Offerings
7.8.4 Takeda Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.8.5 Takeda Key News
7.9 CSL Behring
7.9.1 CSL Behring Corporate Summary
7.9.2 CSL Behring Business Overview
7.9.3 CSL Behring Haemophilia Treatment Major Product Offerings
7.9.4 CSL Behring Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.9.5 CSL Behring Key News
7.10 Alnylam Pharmaceuticals
7.10.1 Alnylam Pharmaceuticals Corporate Summary
7.10.2 Alnylam Pharmaceuticals Business Overview
7.10.3 Alnylam Pharmaceuticals Haemophilia Treatment Major Product Offerings
7.10.4 Alnylam Pharmaceuticals Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.10.5 Alnylam Pharmaceuticals Key News
8 GLOBAL HAEMOPHILIA TREATMENT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Haemophilia Treatment Production Capacity, 2017-2028
8.2 Haemophilia Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Haemophilia Treatment Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HAEMOPHILIA TREATMENT SUPPLY CHAIN ANALYSIS
10.1 Haemophilia Treatment Industry Value Chain
10.2 Haemophilia Treatment Upstream Market
10.3 Haemophilia Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Haemophilia Treatment Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Haemophilia Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Haemophilia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL HAEMOPHILIA TREATMENT OVERALL MARKET SIZE
2.1 Global Haemophilia Treatment Market Size: 2021 VS 2028
2.2 Global Haemophilia Treatment Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Haemophilia Treatment Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Haemophilia Treatment Players in Global Market
3.2 Top Global Haemophilia Treatment Companies Ranked by Revenue
3.3 Global Haemophilia Treatment Revenue by Companies
3.4 Global Haemophilia Treatment Sales by Companies
3.5 Global Haemophilia Treatment Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Haemophilia Treatment Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Haemophilia Treatment Product Type
3.8 Tier 1, Tier 2 and Tier 3 Haemophilia Treatment Players in Global Market
3.8.1 List of Global Tier 1 Haemophilia Treatment Companies
3.8.2 List of Global Tier 2 and Tier 3 Haemophilia Treatment Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Haemophilia Treatment Market Size Markets, 2021 & 2028
4.1.2 Haemophilia A
4.1.3 Haemophilia B
4.2 By Type - Global Haemophilia Treatment Revenue & Forecasts
4.2.1 By Type - Global Haemophilia Treatment Revenue, 2017-2022
4.2.2 By Type - Global Haemophilia Treatment Revenue, 2023-2028
4.2.3 By Type - Global Haemophilia Treatment Revenue Market Share, 2017-2028
4.3 By Type - Global Haemophilia Treatment Sales & Forecasts
4.3.1 By Type - Global Haemophilia Treatment Sales, 2017-2022
4.3.2 By Type - Global Haemophilia Treatment Sales, 2023-2028
4.3.3 By Type - Global Haemophilia Treatment Sales Market Share, 2017-2028
4.4 By Type - Global Haemophilia Treatment Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Haemophilia Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Pharmaceutical Companies
5.1.4 Other
5.2 By Application - Global Haemophilia Treatment Revenue & Forecasts
5.2.1 By Application - Global Haemophilia Treatment Revenue, 2017-2022
5.2.2 By Application - Global Haemophilia Treatment Revenue, 2023-2028
5.2.3 By Application - Global Haemophilia Treatment Revenue Market Share, 2017-2028
5.3 By Application - Global Haemophilia Treatment Sales & Forecasts
5.3.1 By Application - Global Haemophilia Treatment Sales, 2017-2022
5.3.2 By Application - Global Haemophilia Treatment Sales, 2023-2028
5.3.3 By Application - Global Haemophilia Treatment Sales Market Share, 2017-2028
5.4 By Application - Global Haemophilia Treatment Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Haemophilia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Haemophilia Treatment Revenue & Forecasts
6.2.1 By Region - Global Haemophilia Treatment Revenue, 2017-2022
6.2.2 By Region - Global Haemophilia Treatment Revenue, 2023-2028
6.2.3 By Region - Global Haemophilia Treatment Revenue Market Share, 2017-2028
6.3 By Region - Global Haemophilia Treatment Sales & Forecasts
6.3.1 By Region - Global Haemophilia Treatment Sales, 2017-2022
6.3.2 By Region - Global Haemophilia Treatment Sales, 2023-2028
6.3.3 By Region - Global Haemophilia Treatment Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Haemophilia Treatment Revenue, 2017-2028
6.4.2 By Country - North America Haemophilia Treatment Sales, 2017-2028
6.4.3 US Haemophilia Treatment Market Size, 2017-2028
6.4.4 Canada Haemophilia Treatment Market Size, 2017-2028
6.4.5 Mexico Haemophilia Treatment Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Haemophilia Treatment Revenue, 2017-2028
6.5.2 By Country - Europe Haemophilia Treatment Sales, 2017-2028
6.5.3 Germany Haemophilia Treatment Market Size, 2017-2028
6.5.4 France Haemophilia Treatment Market Size, 2017-2028
6.5.5 U.K. Haemophilia Treatment Market Size, 2017-2028
6.5.6 Italy Haemophilia Treatment Market Size, 2017-2028
6.5.7 Russia Haemophilia Treatment Market Size, 2017-2028
6.5.8 Nordic Countries Haemophilia Treatment Market Size, 2017-2028
6.5.9 Benelux Haemophilia Treatment Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Haemophilia Treatment Revenue, 2017-2028
6.6.2 By Region - Asia Haemophilia Treatment Sales, 2017-2028
6.6.3 China Haemophilia Treatment Market Size, 2017-2028
6.6.4 Japan Haemophilia Treatment Market Size, 2017-2028
6.6.5 South Korea Haemophilia Treatment Market Size, 2017-2028
6.6.6 Southeast Asia Haemophilia Treatment Market Size, 2017-2028
6.6.7 India Haemophilia Treatment Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Haemophilia Treatment Revenue, 2017-2028
6.7.2 By Country - South America Haemophilia Treatment Sales, 2017-2028
6.7.3 Brazil Haemophilia Treatment Market Size, 2017-2028
6.7.4 Argentina Haemophilia Treatment Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Haemophilia Treatment Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Haemophilia Treatment Sales, 2017-2028
6.8.3 Turkey Haemophilia Treatment Market Size, 2017-2028
6.8.4 Israel Haemophilia Treatment Market Size, 2017-2028
6.8.5 Saudi Arabia Haemophilia Treatment Market Size, 2017-2028
6.8.6 UAE Haemophilia Treatment Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Haemophilia Treatment Major Product Offerings
7.1.4 Bayer Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.1.5 Bayer Key News
7.2 Novo Nordisk
7.2.1 Novo Nordisk Corporate Summary
7.2.2 Novo Nordisk Business Overview
7.2.3 Novo Nordisk Haemophilia Treatment Major Product Offerings
7.2.4 Novo Nordisk Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.2.5 Novo Nordisk Key News
7.3 Pfizer
7.3.1 Pfizer Corporate Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Haemophilia Treatment Major Product Offerings
7.3.4 Pfizer Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.3.5 Pfizer Key News
7.4 Roche
7.4.1 Roche Corporate Summary
7.4.2 Roche Business Overview
7.4.3 Roche Haemophilia Treatment Major Product Offerings
7.4.4 Roche Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.4.5 Roche Key News
7.5 Aptevo Therapeutics
7.5.1 Aptevo Therapeutics Corporate Summary
7.5.2 Aptevo Therapeutics Business Overview
7.5.3 Aptevo Therapeutics Haemophilia Treatment Major Product Offerings
7.5.4 Aptevo Therapeutics Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.5.5 Aptevo Therapeutics Key News
7.6 Catalyst BioSciences
7.6.1 Catalyst BioSciences Corporate Summary
7.6.2 Catalyst BioSciences Business Overview
7.6.3 Catalyst BioSciences Haemophilia Treatment Major Product Offerings
7.6.4 Catalyst BioSciences Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.6.5 Catalyst BioSciences Key News
7.7 Dimension Therapeutics
7.7.1 Dimension Therapeutics Corporate Summary
7.7.2 Dimension Therapeutics Business Overview
7.7.3 Dimension Therapeutics Haemophilia Treatment Major Product Offerings
7.7.4 Dimension Therapeutics Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.7.5 Dimension Therapeutics Key News
7.8 Takeda
7.8.1 Takeda Corporate Summary
7.8.2 Takeda Business Overview
7.8.3 Takeda Haemophilia Treatment Major Product Offerings
7.8.4 Takeda Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.8.5 Takeda Key News
7.9 CSL Behring
7.9.1 CSL Behring Corporate Summary
7.9.2 CSL Behring Business Overview
7.9.3 CSL Behring Haemophilia Treatment Major Product Offerings
7.9.4 CSL Behring Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.9.5 CSL Behring Key News
7.10 Alnylam Pharmaceuticals
7.10.1 Alnylam Pharmaceuticals Corporate Summary
7.10.2 Alnylam Pharmaceuticals Business Overview
7.10.3 Alnylam Pharmaceuticals Haemophilia Treatment Major Product Offerings
7.10.4 Alnylam Pharmaceuticals Haemophilia Treatment Sales and Revenue in Global (2017-2022)
7.10.5 Alnylam Pharmaceuticals Key News
8 GLOBAL HAEMOPHILIA TREATMENT PRODUCTION CAPACITY, ANALYSIS
8.1 Global Haemophilia Treatment Production Capacity, 2017-2028
8.2 Haemophilia Treatment Production Capacity of Key Manufacturers in Global Market
8.3 Global Haemophilia Treatment Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 HAEMOPHILIA TREATMENT SUPPLY CHAIN ANALYSIS
10.1 Haemophilia Treatment Industry Value Chain
10.2 Haemophilia Treatment Upstream Market
10.3 Haemophilia Treatment Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Haemophilia Treatment Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Haemophilia Treatment in Global Market
Table 2. Top Haemophilia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Haemophilia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Haemophilia Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Haemophilia Treatment Sales by Companies, (K Units), 2017-2022
Table 6. Global Haemophilia Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Haemophilia Treatment Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Haemophilia Treatment Product Type
Table 9. List of Global Tier 1 Haemophilia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Haemophilia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Haemophilia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Haemophilia Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Haemophilia Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Haemophilia Treatment Sales (K Units), 2017-2022
Table 15. By Type - Global Haemophilia Treatment Sales (K Units), 2023-2028
Table 16. By Application – Global Haemophilia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Haemophilia Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Haemophilia Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Haemophilia Treatment Sales (K Units), 2017-2022
Table 20. By Application - Global Haemophilia Treatment Sales (K Units), 2023-2028
Table 21. By Region – Global Haemophilia Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Haemophilia Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Haemophilia Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Haemophilia Treatment Sales (K Units), 2017-2022
Table 25. By Region - Global Haemophilia Treatment Sales (K Units), 2023-2028
Table 26. By Country - North America Haemophilia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Haemophilia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Haemophilia Treatment Sales, (K Units), 2017-2022
Table 29. By Country - North America Haemophilia Treatment Sales, (K Units), 2023-2028
Table 30. By Country - Europe Haemophilia Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Haemophilia Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Haemophilia Treatment Sales, (K Units), 2017-2022
Table 33. By Country - Europe Haemophilia Treatment Sales, (K Units), 2023-2028
Table 34. By Region - Asia Haemophilia Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Haemophilia Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Haemophilia Treatment Sales, (K Units), 2017-2022
Table 37. By Region - Asia Haemophilia Treatment Sales, (K Units), 2023-2028
Table 38. By Country - South America Haemophilia Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Haemophilia Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Haemophilia Treatment Sales, (K Units), 2017-2022
Table 41. By Country - South America Haemophilia Treatment Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Haemophilia Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Haemophilia Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Haemophilia Treatment Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Haemophilia Treatment Sales, (K Units), 2023-2028
Table 46. Bayer Corporate Summary
Table 47. Bayer Haemophilia Treatment Product Offerings
Table 48. Bayer Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Novo Nordisk Corporate Summary
Table 50. Novo Nordisk Haemophilia Treatment Product Offerings
Table 51. Novo Nordisk Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Haemophilia Treatment Product Offerings
Table 54. Pfizer Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Roche Corporate Summary
Table 56. Roche Haemophilia Treatment Product Offerings
Table 57. Roche Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Aptevo Therapeutics Corporate Summary
Table 59. Aptevo Therapeutics Haemophilia Treatment Product Offerings
Table 60. Aptevo Therapeutics Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Catalyst BioSciences Corporate Summary
Table 62. Catalyst BioSciences Haemophilia Treatment Product Offerings
Table 63. Catalyst BioSciences Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Dimension Therapeutics Corporate Summary
Table 65. Dimension Therapeutics Haemophilia Treatment Product Offerings
Table 66. Dimension Therapeutics Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Takeda Corporate Summary
Table 68. Takeda Haemophilia Treatment Product Offerings
Table 69. Takeda Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. CSL Behring Corporate Summary
Table 71. CSL Behring Haemophilia Treatment Product Offerings
Table 72. CSL Behring Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Alnylam Pharmaceuticals Corporate Summary
Table 74. Alnylam Pharmaceuticals Haemophilia Treatment Product Offerings
Table 75. Alnylam Pharmaceuticals Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Haemophilia Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Haemophilia Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Haemophilia Treatment Production by Region, 2017-2022 (K Units)
Table 79. Global Haemophilia Treatment Production by Region, 2023-2028 (K Units)
Table 80. Haemophilia Treatment Market Opportunities & Trends in Global Market
Table 81. Haemophilia Treatment Market Drivers in Global Market
Table 82. Haemophilia Treatment Market Restraints in Global Market
Table 83. Haemophilia Treatment Raw Materials
Table 84. Haemophilia Treatment Raw Materials Suppliers in Global Market
Table 85. Typical Haemophilia Treatment Downstream
Table 86. Haemophilia Treatment Downstream Clients in Global Market
Table 87. Haemophilia Treatment Distributors and Sales Agents in Global Market
Table 1. Key Players of Haemophilia Treatment in Global Market
Table 2. Top Haemophilia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Haemophilia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Haemophilia Treatment Revenue Share by Companies, 2017-2022
Table 5. Global Haemophilia Treatment Sales by Companies, (K Units), 2017-2022
Table 6. Global Haemophilia Treatment Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Haemophilia Treatment Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Haemophilia Treatment Product Type
Table 9. List of Global Tier 1 Haemophilia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Haemophilia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Haemophilia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Haemophilia Treatment Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Haemophilia Treatment Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Haemophilia Treatment Sales (K Units), 2017-2022
Table 15. By Type - Global Haemophilia Treatment Sales (K Units), 2023-2028
Table 16. By Application – Global Haemophilia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Haemophilia Treatment Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Haemophilia Treatment Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Haemophilia Treatment Sales (K Units), 2017-2022
Table 20. By Application - Global Haemophilia Treatment Sales (K Units), 2023-2028
Table 21. By Region – Global Haemophilia Treatment Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Haemophilia Treatment Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Haemophilia Treatment Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Haemophilia Treatment Sales (K Units), 2017-2022
Table 25. By Region - Global Haemophilia Treatment Sales (K Units), 2023-2028
Table 26. By Country - North America Haemophilia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Haemophilia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Haemophilia Treatment Sales, (K Units), 2017-2022
Table 29. By Country - North America Haemophilia Treatment Sales, (K Units), 2023-2028
Table 30. By Country - Europe Haemophilia Treatment Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Haemophilia Treatment Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Haemophilia Treatment Sales, (K Units), 2017-2022
Table 33. By Country - Europe Haemophilia Treatment Sales, (K Units), 2023-2028
Table 34. By Region - Asia Haemophilia Treatment Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Haemophilia Treatment Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Haemophilia Treatment Sales, (K Units), 2017-2022
Table 37. By Region - Asia Haemophilia Treatment Sales, (K Units), 2023-2028
Table 38. By Country - South America Haemophilia Treatment Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Haemophilia Treatment Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Haemophilia Treatment Sales, (K Units), 2017-2022
Table 41. By Country - South America Haemophilia Treatment Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Haemophilia Treatment Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Haemophilia Treatment Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Haemophilia Treatment Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Haemophilia Treatment Sales, (K Units), 2023-2028
Table 46. Bayer Corporate Summary
Table 47. Bayer Haemophilia Treatment Product Offerings
Table 48. Bayer Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Novo Nordisk Corporate Summary
Table 50. Novo Nordisk Haemophilia Treatment Product Offerings
Table 51. Novo Nordisk Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Pfizer Corporate Summary
Table 53. Pfizer Haemophilia Treatment Product Offerings
Table 54. Pfizer Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Roche Corporate Summary
Table 56. Roche Haemophilia Treatment Product Offerings
Table 57. Roche Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Aptevo Therapeutics Corporate Summary
Table 59. Aptevo Therapeutics Haemophilia Treatment Product Offerings
Table 60. Aptevo Therapeutics Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Catalyst BioSciences Corporate Summary
Table 62. Catalyst BioSciences Haemophilia Treatment Product Offerings
Table 63. Catalyst BioSciences Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Dimension Therapeutics Corporate Summary
Table 65. Dimension Therapeutics Haemophilia Treatment Product Offerings
Table 66. Dimension Therapeutics Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Takeda Corporate Summary
Table 68. Takeda Haemophilia Treatment Product Offerings
Table 69. Takeda Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. CSL Behring Corporate Summary
Table 71. CSL Behring Haemophilia Treatment Product Offerings
Table 72. CSL Behring Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Alnylam Pharmaceuticals Corporate Summary
Table 74. Alnylam Pharmaceuticals Haemophilia Treatment Product Offerings
Table 75. Alnylam Pharmaceuticals Haemophilia Treatment Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Haemophilia Treatment Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Haemophilia Treatment Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Haemophilia Treatment Production by Region, 2017-2022 (K Units)
Table 79. Global Haemophilia Treatment Production by Region, 2023-2028 (K Units)
Table 80. Haemophilia Treatment Market Opportunities & Trends in Global Market
Table 81. Haemophilia Treatment Market Drivers in Global Market
Table 82. Haemophilia Treatment Market Restraints in Global Market
Table 83. Haemophilia Treatment Raw Materials
Table 84. Haemophilia Treatment Raw Materials Suppliers in Global Market
Table 85. Typical Haemophilia Treatment Downstream
Table 86. Haemophilia Treatment Downstream Clients in Global Market
Table 87. Haemophilia Treatment Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Haemophilia Treatment Segment by Type
Figure 2. Haemophilia Treatment Segment by Application
Figure 3. Global Haemophilia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Haemophilia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Haemophilia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Haemophilia Treatment Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Haemophilia Treatment Revenue in 2021
Figure 9. By Type - Global Haemophilia Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Haemophilia Treatment Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Haemophilia Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Haemophilia Treatment Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Haemophilia Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Haemophilia Treatment Sales Market Share, 2017-2028
Figure 19. US Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Haemophilia Treatment Sales Market Share, 2017-2028
Figure 24. Germany Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Haemophilia Treatment Sales Market Share, 2017-2028
Figure 33. China Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Haemophilia Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Haemophilia Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Haemophilia Treatment Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Haemophilia Treatment by Region, 2021 VS 2028
Figure 50. Haemophilia Treatment Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Haemophilia Treatment Segment by Type
Figure 2. Haemophilia Treatment Segment by Application
Figure 3. Global Haemophilia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Haemophilia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Haemophilia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. Haemophilia Treatment Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Haemophilia Treatment Revenue in 2021
Figure 9. By Type - Global Haemophilia Treatment Sales Market Share, 2017-2028
Figure 10. By Type - Global Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 11. By Type - Global Haemophilia Treatment Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Haemophilia Treatment Sales Market Share, 2017-2028
Figure 13. By Application - Global Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 14. By Application - Global Haemophilia Treatment Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Haemophilia Treatment Sales Market Share, 2017-2028
Figure 16. By Region - Global Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 17. By Country - North America Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 18. By Country - North America Haemophilia Treatment Sales Market Share, 2017-2028
Figure 19. US Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Haemophilia Treatment Sales Market Share, 2017-2028
Figure 24. Germany Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. France Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Haemophilia Treatment Sales Market Share, 2017-2028
Figure 33. China Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. India Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 39. By Country - South America Haemophilia Treatment Sales Market Share, 2017-2028
Figure 40. Brazil Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Haemophilia Treatment Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Haemophilia Treatment Sales Market Share, 2017-2028
Figure 44. Turkey Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Haemophilia Treatment Revenue, (US$, Mn), 2017-2028
Figure 48. Global Haemophilia Treatment Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Haemophilia Treatment by Region, 2021 VS 2028
Figure 50. Haemophilia Treatment Industry Value Chain
Figure 51. Marketing Channels
